← Eichor
Condition: Severe Hypertriglyceridemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Hypertriglyceridemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess the Safety, Tolerability and Efficacy of ION775
Phase 2 · 16 location(s) · Ionis Pharmaceuticals, Inc. · NCT07604974The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
Phase N/A · 4 location(s) · University of Michigan · NCT03087253Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyc
Phase 2 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07308392CS-121 APOC3 Base Editing in FCS
EARLY_Phase 1 · 1 location(s) · CorrectSequence Therapeutics Co., Ltd · NCT07176923A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Phase 2 · 41 location(s) · Eli Lilly and Company · NCT07269210Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Phase 3 · 102 location(s) · Arrowhead Pharmaceuticals · NCT06880770
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.